CASPIAN SPINAL SYSTEM

K141284 · K2m, Inc. · KWP · Jul 23, 2014 · Orthopedic

Device Facts

Record IDK141284
Device NameCASPIAN SPINAL SYSTEM
ApplicantK2m, Inc.
Product CodeKWP · Orthopedic
Decision DateJul 23, 2014
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3050
Device ClassClass 2
AttributesTherapeutic

Intended Use

The CASPIAN OCT/MESA Mini/ DENALI Mini Spinal System is intended to provide stabilization as an adjunct to fusion of the cervical spine and occipito-cervico-thoracic junction (occiput-T3) when used with autograft or allograft and indicated for the following: DDD (neck pain of discogenic origin with degeneration of the disc as confirmed by patient history and radiographic studies) Spondylolisthesis Spinal stenosis Fracture/dislocation Revision of previous cervical spine surgery Tumors Atlantoaxial fracture with instability Occipitocervical dislocation The occipital bone screws are limited to occipital fixation only The rod and hook components are intended for use in the cervical/upper thoracic (C1-T3) spine. The pedicle screws are limited to placement in the TI-T3 in treating thoracic conditions only. The pedicle screws are not intended to be placed in or treat conditions involving the cervical spine. The CASPIAN OCT/MESA Mini/ DENALI Mini System can also be linked to the Range Spinal System using rod connectors or transitional rods.

Device Story

Top-loading, posterior spinal fixation system; provides immobilization/stabilization as adjunct to fusion. Components include rods, hooks, and screws; manufactured from Ti6Al4V Eli. Used in occipital-cervical-thoracic spine (occiput-T3). Surgeon-operated in clinical/OR setting. System provides mechanical support to spine; stabilizes segments during fusion process. Can link to Range Spinal System via connectors/transitional rods.

Clinical Evidence

Bench testing only. Mechanical testing performed in accordance with ASTM F1717. Finite element analysis used to evaluate new rod components.

Technological Characteristics

Top-loading posterior spinal fixation system. Materials: Ti6Al4V Eli per ASTM and ISO standards. Mechanical testing per ASTM F1717. Components: rods, hooks, pedicle screws, occipital screws. Connectivity: mechanical linkage to Range Spinal System.

Indications for Use

Indicated for patients requiring stabilization as an adjunct to fusion of the cervical spine and occipito-cervico-thoracic junction (occiput-T3) for conditions including DDD, spondylolisthesis, spinal stenosis, fracture/dislocation, revision surgery, tumors, atlantoaxial fracture with instability, and occipitocervical dislocation. Pedicle screws restricted to T1-T3 thoracic conditions; not for cervical spine use.

Regulatory Classification

Identification

A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # JIII 2 3 2014 510(k) Summary For the # CASPIAN OCT/MESA Mini/ DENALI Mini System This 510(k) summary for the CASPIAN OCT/MESA Mini/ DENALI Mini System is provided as required per Section 513(i)(3) of the Food, Drug and Cosmetic Act. ### 1. Submitter: K2M, Inc. 751 Miller Drive SE Leesburg, VA 20175 ### Contact Person: Nancy Giezen K2M, Inc. Telephone: 703-777-3155 Date Prepared: 07/22/2014 | 2. Tradename: | CASPIAN OCT/MESA Mini/ DENALI Mini System | |----------------------|---------------------------------------------------------| | Common Name: | Spinal Fixation System | | Classification Name: | Spinal Interlaminal Fixation Orthosis (21 CFR 888.3050) | | Device Product Code: | KWP | | Regulatory Class: | Class II | ### 3. Predicate or legally marketed devices which are substantially equivalent: - . K2M Caspian Spinal System (K081107) - K2M Caspian OCT Spinal System (K101084) . - Biomet Altius System (K033961, K043229, K122378) . ### 4. Description of the device: The CASPIAN OCT/MESA Mini/ DENALI Mini System is a top-loading, multiple component, posterior (occipital-cervical-thoracic) spinal fixation system. The purpose of the current submission is to add 03.5 contoured rods to expand the rod offerings for the system. Materials: The subject devices are manufactured from Ti6Al4V Eli per ASTM and ISO standards. Function: The system functions as an adjunct to fusion to provide immobilization of stabilization of the posterior cervical and thoracic spine. ### 5. Intended Use: The CASPIAN OCT/MESA Mini/ DENALI Mini Spinal System is intended to provide stabilization as an adjunct to fusion of the cervical spine and occipito-cervico-thoracic junction (occiput-T3) when used with autograft or allograft and indicated for the following: - . DDD (neck pain of discogenic origin with degeneration of the disc as confirmed by patient history and radiographic studies) {1}------------------------------------------------ - Spondylolisthesis . - Spinal stenosis . - Fracture/dislocation . - Revision of previous cervical spine surgery ● - Tumors � - Atlantoaxial fracture with instability . - Occipitocervical dislocation . The occipital bone screws are limited to occipital fixation only The rod and hook components are intended for use in the cervical/upper thoracic (C1-T3) spine. The pedicle screws are limited to placement in the TI-T3 in treating thoracic conditions only. The pedicle screws are not intended to be placed in or treat conditions involving the cervical spine. The CASPIAN OCT/MESA Mini/ DENALI Mini System can also be linked to the Range Spinal System using rod connectors or transitional rods. - 6. Comparison of the technology characteristics of the device to predicate and legally marketed devices: The worst case components of the CASPIAN OCT/MESA Mini/ DENALI Mini System were previously tested in accordance with ASTM F1717 and determined to be equivalent to predicate devices. The subject rods were determined not to represent a new worst case via finite element analysis and engineering rationale. There are no significant differences between the CASPIAN OCT/MESA Mini/ DENALI Mini System and other systems currently being marketed which would adversely affect the use of the product. It is substantially equivalent to these other devices in design, function, material and intended use, {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 July 23, 2014 K2M. Incorporated Ms. Nancy Giezen Manager, Regulatory Affairs 751 Miller Drive Southeast Leesburg. Virginia 20175 Re: K141284 Trade/Device Name: CASPIAN OCT/MESA Mini/DENALI Mini Spinal System Regulation Number: 21 CFR 888.3050 Regulation Name: Spinal interlaminal fixation orthosis Regulatory Class: Class II Product Code: KWP Dated: June 23, 2014 Received: June 24, 2014 Dear Ms. Giezen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH docs not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complics with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {3}------------------------------------------------ Page 2 - Ms. Nancy Giezen forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/McdicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Ronald P. Jean -S for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below. 510(k) Number (if known) K141284 Device Name CASPIAN OCT/MESA Mini/ DENALI Mini Spinal System ### Indications for Use (Describe) The CASPIAN OCT/MESA Mini/ DENALI Mini Spinal System is intended to provide stabilization as an adjunct to fusion of the cervical spine and occipito-cervico-thoracic junction (occiput-T3) when used with autograft or allograft and indicated for the following: · DDD (neck pain of discogenic origin with degeneration of the disc as confirmed by patient history and radiographic studies) - · Spondylolisthesis - Spinal stenosis - · Fracture/dislocation - · Revision of previous cervical spine surgery - · Tumors - · Atlantoaxial fracture with instability - · Occipitocervical dislocation The occipital bone screws are limited to occipital fixation only The rod and hook components are in the cervical/upper thoracic (CI-T3) spine. The pedicle screws are limited to placement in the TI-T3 in treating thoracic conditions only. The pedicle screws are not intended to be placed in or treat conditions involving the cervical spine. The CASPIAN OCT/MESA Mini/ DENALI Mini System can also be linked to the Range Spinal System using rod connectors or transitional rods. Type of Use (Select one or both, as applicable) Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) # PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED. # FOR FDA USE ONLY Concurrence of Center for Devices and Radiological Health (CDRH) (Signature) # Jonathan H. Peck -S {5}------------------------------------------------ This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW." The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@lda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%